These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35567903)

  • 21. Chitotriosidase as biomarker for early stage amyotrophic lateral sclerosis: a multicenter study.
    Steinacker P; Feneberg E; Halbgebauer S; Witzel S; Verde F; Oeckl P; Van Damme P; Gaur N; Gray E; Grosskreutz J; Jardel CG; Kachanov M; Kuhle J; Lamari F; Maceski A; Del Mar Amador M; Mayer B; Morelli C; Petri S; Poesen K; Raaphorst J; Salachas F; Silani V; Turner MR; Verbeek MM; Volk AE; Weishaupt JH; Weydt P; Ludolph AC; Otto M
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 May; 22(3-4):276-286. PubMed ID: 33576252
    [No Abstract]   [Full Text] [Related]  

  • 22. Monitoring CSF proteome alterations in amyotrophic lateral sclerosis: obstacles and perspectives in translating a novel marker panel to the clinic.
    von Neuhoff N; Oumeraci T; Wolf T; Kollewe K; Bewerunge P; Neumann B; Brors B; Bufler J; Wurster U; Schlegelberger B; Dengler R; Zapatka M; Petri S
    PLoS One; 2012; 7(9):e44401. PubMed ID: 22970211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomics characterization of extracellular vesicles sorted by flow cytometry reveals a disease-specific molecular cross-talk from cerebrospinal fluid and tears in multiple sclerosis.
    Pieragostino D; Lanuti P; Cicalini I; Cufaro MC; Ciccocioppo F; Ronci M; Simeone P; Onofrj M; van der Pol E; Fontana A; Marchisio M; Del Boccio P
    J Proteomics; 2019 Jul; 204():103403. PubMed ID: 31170500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased cerebrospinal fluid adenosine 5'-triphosphate in patients with amyotrophic lateral sclerosis.
    Nukui T; Matsui A; Niimi H; Sugimoto T; Hayashi T; Dougu N; Konishi H; Yamamoto M; Anada R; Matsuda N; Kitajima I; Nakatsuji Y
    BMC Neurol; 2021 Jun; 21(1):255. PubMed ID: 34193068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebrospinal Fluid Neurofilaments May Discriminate Upper Motor Neuron Syndromes: A Pilot Study.
    Zucchi E; Bedin R; Fasano A; Fini N; Gessani A; Vinceti M; Mandrioli J
    Neurodegener Dis; 2018; 18(5-6):255-261. PubMed ID: 30428468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a circulating miRNA signature in extracellular vesicles collected from amyotrophic lateral sclerosis patients.
    Saucier D; Wajnberg G; Roy J; Beauregard AP; Chacko S; Crapoulet N; Fournier S; Ghosh A; Lewis SM; Marrero A; O'Connell C; Ouellette RJ; Morin PJ
    Brain Res; 2019 Apr; 1708():100-108. PubMed ID: 30552897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis.
    Thompson AG; Gray E; Thézénas ML; Charles PD; Evetts S; Hu MT; Talbot K; Fischer R; Kessler BM; Turner MR
    Ann Neurol; 2018 Feb; 83(2):258-268. PubMed ID: 29331073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different CSF protein profiles in amyotrophic lateral sclerosis and frontotemporal dementia with
    Barschke P; Oeckl P; Steinacker P; Al Shweiki MR; Weishaupt JH; Landwehrmeyer GB; Anderl-Straub S; Weydt P; Diehl-Schmid J; Danek A; Kornhuber J; Schroeter ML; Prudlo J; Jahn H; Fassbender K; Lauer M; van der Ende EL; van Swieten JC; Volk AE; Ludolph AC; Otto M;
    J Neurol Neurosurg Psychiatry; 2020 May; 91(5):503-511. PubMed ID: 32132225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Proteomic analysis of the cerebrospinal fluid from patients with amyotrophic lateral sclerosis based on tandem mass spectrometry technique].
    Su D; Zhang Y; Bi F; Xiao B
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Apr; 39(4):428-436. PubMed ID: 31068286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring Cerebrospinal Fluid IgG N-Glycosylation as Potential Biomarker for Amyotrophic Lateral Sclerosis.
    Costa J; Streich L; Pinto S; Pronto-Laborinho A; Nimtz M; Conradt HS; de Carvalho M
    Mol Neurobiol; 2019 Aug; 56(8):5729-5739. PubMed ID: 30674035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid.
    Otake K; Kamiguchi H; Hirozane Y
    BMC Med Genomics; 2019 Jan; 12(1):7. PubMed ID: 30630471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebrospinal fluid levels of chromogranin A and phosphorylated neurofilament heavy chain are elevated in amyotrophic lateral sclerosis.
    Kaiserova M; Grambalova Z; Otruba P; Stejskal D; Prikrylova Vranova H; Mares J; Mensikova K; Kanovsky P
    Acta Neurol Scand; 2017 Oct; 136(4):360-364. PubMed ID: 28185258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomarker-based predictive models for prognosis in amyotrophic lateral sclerosis.
    Su XW; Simmons Z; Mitchell RM; Kong L; Stephens HE; Connor JR
    JAMA Neurol; 2013 Dec; 70(12):1505-11. PubMed ID: 24145899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decoding distinctive features of plasma extracellular vesicles in amyotrophic lateral sclerosis.
    Pasetto L; Callegaro S; Corbelli A; Fiordaliso F; Ferrara D; Brunelli L; Sestito G; Pastorelli R; Bianchi E; Cretich M; Chiari M; Potrich C; Moglia C; Corbo M; Sorarù G; Lunetta C; Calvo A; Chiò A; Mora G; Pennuto M; Quattrone A; Rinaldi F; D'Agostino VG; Basso M; Bonetto V
    Mol Neurodegener; 2021 Aug; 16(1):52. PubMed ID: 34376243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of miRNAs as Potential Biomarkers in Cerebrospinal Fluid from Amyotrophic Lateral Sclerosis Patients.
    Benigni M; Ricci C; Jones AR; Giannini F; Al-Chalabi A; Battistini S
    Neuromolecular Med; 2016 Dec; 18(4):551-560. PubMed ID: 27119371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Revealing the Proteome of Motor Cortex Derived Extracellular Vesicles Isolated from Amyotrophic Lateral Sclerosis Human Postmortem Tissues.
    Vassileff N; Vella LJ; Rajapaksha H; Shambrook M; Kenari AN; McLean C; Hill AF; Cheng L
    Cells; 2020 Jul; 9(7):. PubMed ID: 32708779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent Advances in Extracellular Vesicles in Amyotrophic Lateral Sclerosis and Emergent Perspectives.
    Afonso GJM; Cavaleiro C; Valero J; Mota SI; Ferreiro E
    Cells; 2023 Jul; 12(13):. PubMed ID: 37443797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CSF cystatin C and diffusion tensor imaging parameters as biomarkers of upper motor neuron degeneration in amyotrophic lateral sclerosis.
    Nakane S; Fujita K; Azuma S; Urushihara R; Kamada M; Harada M; Izumi Y; Kaji R
    Clin Neurol Neurosurg; 2018 Sep; 172():162-168. PubMed ID: 30016754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicentre quality control evaluation of different biomarker candidates for amyotrophic lateral sclerosis.
    Lehnert S; Costa J; de Carvalho M; Kirby J; Kuzma-Kozakiewicz M; Morelli C; Robberecht W; Shaw P; Silani V; Steinacker P; Tumani H; Van Damme P; Ludolph A; Otto M
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Sep; 15(5-6):344-50. PubMed ID: 24575871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis.
    Mitchell RM; Freeman WM; Randazzo WT; Stephens HE; Beard JL; Simmons Z; Connor JR
    Neurology; 2009 Jan; 72(1):14-9. PubMed ID: 18987350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.